IL103436A0 - Substituted pyrimidines,their preparation and pharmaceutical compositions containing them - Google Patents

Substituted pyrimidines,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL103436A0
IL103436A0 IL103436A IL10343692A IL103436A0 IL 103436 A0 IL103436 A0 IL 103436A0 IL 103436 A IL103436 A IL 103436A IL 10343692 A IL10343692 A IL 10343692A IL 103436 A0 IL103436 A0 IL 103436A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
preparation
compositions containing
substituted pyrimidines
treating
Prior art date
Application number
IL103436A
Other versions
IL103436A (en
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/782,025 external-priority patent/US5149699A/en
Priority claimed from GB9207560A external-priority patent/GB2265899A/en
Priority claimed from US07/901,485 external-priority patent/US5256654A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL103436A0 publication Critical patent/IL103436A0/en
Publication of IL103436A publication Critical patent/IL103436A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Abstract

This invention relates to pyrrolo-, pyrido-, azepino-, and azocinopyrimidines of the general formula I <CHEM> useful for treating hypertension or congestive heart failure and for preventing or treating restenosis following angioplasty, to pharmaceutical compositions, and to methods for production thereof.
IL10343692A 1991-10-24 1992-10-15 Substituted condensed bicyclic pyrimidinones their preparation and pharmaceutical compositions containing them IL103436A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/782,025 US5149699A (en) 1991-10-24 1991-10-24 Substituted pyridopyrimidines useful as antgiotensin II antagonists
GB9207560A GB2265899A (en) 1992-04-07 1992-04-07 Substituted pyrimidines
US07/901,485 US5256654A (en) 1991-10-24 1992-06-25 Substituted pyrrolopyrimidines, azepinopyrimidines and pyridopyrimidines useful as angiotensin II antagonists

Publications (2)

Publication Number Publication Date
IL103436A0 true IL103436A0 (en) 1993-03-15
IL103436A IL103436A (en) 1996-03-31

Family

ID=27266132

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10343692A IL103436A (en) 1991-10-24 1992-10-15 Substituted condensed bicyclic pyrimidinones their preparation and pharmaceutical compositions containing them

Country Status (21)

Country Link
EP (1) EP0539086B1 (en)
JP (1) JP3240192B2 (en)
KR (1) KR100286624B1 (en)
CN (2) CN1039324C (en)
AT (1) ATE161537T1 (en)
AU (1) AU653635B2 (en)
CA (1) CA2080705C (en)
DE (1) DE69223734T2 (en)
DK (1) DK0539086T3 (en)
ES (1) ES2111617T3 (en)
FI (1) FI103971B1 (en)
GR (1) GR3025926T3 (en)
HK (1) HK1003031A1 (en)
HU (2) HU218786B (en)
IL (1) IL103436A (en)
LV (1) LV12047B (en)
NO (1) NO301275B1 (en)
SG (1) SG47626A1 (en)
SK (1) SK280292B6 (en)
TW (1) TW226375B (en)
UA (1) UA27748C2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0643704T3 (en) * 1991-11-18 2004-01-19 Merck & Co Inc Tetrazolylphenylboronic acid intermediates for the synthesis of All receptor antagonists
EP0618207B1 (en) * 1993-03-24 1999-01-07 American Home Products Corporation Substituted pyridopyrimidines as antihypertensives
ES2129850T3 (en) * 1994-09-20 1999-06-16 Wakunaga Seiyaku Kk PRODUCTION PROCEDURE OF A DERIVATIVE OF N-BIPHENYL METHYLTIADIAZOLINE OR A SALT OF IT AND ITS INTERMEDIATE PRODUCTION OF PRODUCTION.
IT1292437B1 (en) * 1997-06-30 1999-02-08 Zambon Spa ORTHO-METALLATION PROCESS USEFUL FOR THE SYNTHESIS OF 1 - TETRAZOL- 5-IL) 2-SUBSTITUTED BENZENES
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AR033390A1 (en) 2000-08-22 2003-12-17 Novartis Ag A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ATTA RECEIVER ANTAGONIST AND A POTENTIATOR OF THE INSULIN SECRETION, THE USE OF SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND A PARTS KIT
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
GB0402262D0 (en) 2004-02-02 2004-03-10 Novartis Ag Process for the manufacture of organic compounds
US20080161321A1 (en) 2004-03-17 2008-07-03 David Louis Feldman Use of Renin Inhibitors in Therapy
KR20130048281A (en) 2004-10-08 2013-05-09 노파르티스 아게 Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure
EP1749828A1 (en) 2005-08-04 2007-02-07 Farmaprojects S.L. Process for preparing an angiotensin II receptor antagonist
ZA200905537B (en) 2007-03-01 2010-10-27 Probiodrug Ag New use of glutaminyl cyclase inhibitors
JP5667440B2 (en) 2007-04-18 2015-02-12 プロビオドルグ エージー Thiourea derivatives as glutaminyl cyclase inhibitors
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
MX2009012917A (en) * 2007-06-07 2010-01-14 Sigma Tau Ind Farmaceuti 5beta, 14beta-androstane derivatives useful for the treatment of restenosis after angioplastic or endoartherectomy and diseases due to organ fibrosis.
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
MX2012002993A (en) 2009-09-11 2012-04-19 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase.
JP6026284B2 (en) 2010-03-03 2016-11-16 プロビオドルグ エージー Inhibitors of glutaminyl cyclase
MX2012010470A (en) 2010-03-10 2012-10-09 Probiodrug Ag Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012123563A1 (en) 2011-03-16 2012-09-20 Probiodrug Ag Benz imidazole derivatives as inhibitors of glutaminyl cyclase
WO2013090196A1 (en) 2011-12-15 2013-06-20 Takeda Pharmaceuticals U.S.A., Inc. Combinations of azilsartan and chlorthalidone for treating hypertension black patients
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
EP3461819B1 (en) 2017-09-29 2020-05-27 Probiodrug AG Inhibitors of glutaminyl cyclase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
EP0415886A3 (en) * 1989-08-30 1991-10-23 Ciba-Geigy Ag Aza compounds
CA2075627A1 (en) * 1990-02-13 1991-08-14 William J. Greenlee Angiotensin ii antagonists incorporating a substituted benzyl element
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists

Also Published As

Publication number Publication date
NO924121D0 (en) 1992-10-23
LV12047B (en) 1998-08-20
IL103436A (en) 1996-03-31
HU211915A9 (en) 1996-01-29
NO924121L (en) 1993-04-26
EP0539086A3 (en) 1993-06-16
SG47626A1 (en) 1998-04-17
KR930007949A (en) 1993-05-20
DE69223734T2 (en) 1998-04-16
SK322192A3 (en) 1999-11-08
CN1039324C (en) 1998-07-29
FI924397A0 (en) 1992-09-30
ATE161537T1 (en) 1998-01-15
FI103971B (en) 1999-10-29
HK1003031A1 (en) 1998-09-30
HU9203161D0 (en) 1992-12-28
TW226375B (en) 1994-07-11
SK280292B6 (en) 1999-11-08
FI103971B1 (en) 1999-10-29
KR100286624B1 (en) 2001-05-02
CN1072682A (en) 1993-06-02
CA2080705A1 (en) 1993-04-25
AU2607992A (en) 1993-04-29
FI924397A (en) 1993-04-25
NO301275B1 (en) 1997-10-06
LV12047A (en) 1998-05-20
AU653635B2 (en) 1994-10-06
JPH05222039A (en) 1993-08-31
EP0539086A2 (en) 1993-04-28
HUT62893A (en) 1993-06-28
DE69223734D1 (en) 1998-02-05
DK0539086T3 (en) 1998-02-02
GR3025926T3 (en) 1998-04-30
ES2111617T3 (en) 1998-03-16
EP0539086B1 (en) 1997-12-29
CA2080705C (en) 2002-12-03
HU218786B (en) 2000-12-28
CN1175414A (en) 1998-03-11
JP3240192B2 (en) 2001-12-17
UA27748C2 (en) 2000-10-16

Similar Documents

Publication Publication Date Title
IL103436A0 (en) Substituted pyrimidines,their preparation and pharmaceutical compositions containing them
NZ234327A (en) Quinazoline derivatives and pharmaceutical compositions
IL103875A0 (en) Piperazinyl-and piperidinyl-cyclohexanol derivatives and pharmaceutical compositions containing the same
AU1625192A (en) Heterocyclic derivatives
HUT61748A (en) Process for producing angiotensin ii receptor blocking 2,3,6-substituted quinazolinone derivatives and pharmaceutical compositions comprising same
GB9113628D0 (en) Heterocyclic derivatives
DK0609289T3 (en) Imidazole derivatives and pharmaceutical compositions containing them
GB9302046D0 (en) Antiumoral compound-v
DE3483735D1 (en) Hexahydropyrrolo(2,1-a)isochinolinderivate.
FI941309A0 (en) Substituted pyridopyrimidines as antihypertensive agents
JO1697B1 (en) Pyridine derivatives
JO1648B1 (en) Nitrogen compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HCA Change of name of proprietor(s) after amalgamation
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees